[Patients with mild cognition impairment should not be treated with antidementia agents, except in studies]

Dtsch Med Wochenschr. 2008 Apr;133(16):852; author reply 852. doi: 10.1055/s-2008-1075661.
[Article in German]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents*
  • Cognition Disorders / classification*
  • Cognition Disorders / drug therapy*
  • Contraindications
  • Humans
  • Prognosis
  • Severity of Illness Index

Substances

  • Antipsychotic Agents